Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStretch marks are one of the most common injection-site questions our prescribers hear, and the short answer is: it is best to avoid them. Injecting Mounjaro directly into stretched or scarred skin can affect how reliably the medicine is absorbed, and the SmPC guidance on site selection exists for good clinical reasons. Mounjaro (tirzepatide) is a once-weekly subcutaneous injection — a prescription-only medicine that requires clinical assessment before it is prescribed. Choosing the right spot each week is a small habit that makes a real difference to how the treatment performs.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a fair question. Stretch marks look like surface-level marks, so it is tempting to assume the tissue underneath behaves the same as anywhere else. It does not, quite. Stretch marks form when the dermis tears during rapid skin stretching; the resulting scar tissue has a different structure from the surrounding skin, with altered collagen arrangement and sometimes reduced blood vessel density in the immediate area.
Mounjaro is injected subcutaneously, meaning the needle passes through the skin and delivers tirzepatide into the fat layer below. For that fat layer to absorb the medicine consistently, the tissue needs to be reasonably undisturbed. In areas of significant scarring or dense stretch marks, the fat tissue directly beneath can be more fibrous, which may slow or alter absorption. This does not mean a single dose into a stretch mark is wasted (the effect is unlikely to be dramatic) but over weeks of treatment, consistent site selection matters more than any individual injection.
The NHS Mounjaro medicines page and the manufacturer's Patient Information Leaflet both specify rotating between the abdomen, thigh and upper arm, and avoiding injecting into skin that is sore, red, bruised, scarred or broken. Stretch marks that are raised, deep or actively changing fall squarely into that category. The ones that are old, flat and pale are less clearly problematic, but if you want a fuller picture of what happens if you inject Mounjaro into a stretch mark, including how tissue differences can affect absorption, the practical advice is the same: there is enough usable skin elsewhere that the question rarely needs to be tested.
The three licensed sites give you a lot of flexibility. The abdomen is the most commonly used, a large area on either side of the navel, staying at least two finger-widths from the navel itself. Many people find that injecting Mounjaro into the thigh works well, with useful guidance on positioning and technique covered on that page, particularly for those who find the abdomen uncomfortable. The upper arm is a practical option too, covered in more detail for people who prefer it on the arm injection page.
A checking habit worth building: before each injection, spend thirty seconds running a fingertip over your chosen spot. You are looking for any raised texture, tenderness or lumps from a previous injection. If you find any, move a few centimetres away. Rotate in a loose pattern (left side one week, right side the next, or work around a clock-face) so no single area gets used more than once every few weeks.
If stretch marks cover a large part of your abdomen or thighs and you are genuinely unsure where to inject, this is worth raising with your prescriber directly. It is a practical clinical question, and one our team at nume is used to fielding as part of aftercare support.
If it happened once, there is no need for alarm. The dose is not lost. What you want to avoid is making it a habit, for the absorption consistency reasons above. Do not try to re-inject the same dose; just return to a clearer site next week.
What is worth watching for after any injection (regardless of site) is anything unusual at the injection spot: redness that spreads, swelling, warmth or pain that worsens over 24 to 48 hours. These signs could indicate a skin reaction or, rarely, an infection, and are worth contacting a healthcare professional about. The broader Mounjaro injection guidance covers what normal post-injection responses look like versus ones that need attention.
Needle technique also plays a role. Using a fresh needle for every injection (needles blunt faster than most people expect) keeps the injection clean and reduces skin trauma. Replacement needles are available from our pharmacy if you need them. Clean the chosen site first, pinch the skin gently if you have been advised to, and insert at the angle shown in the leaflet. These basics matter as much as which site you choose.
Consistent technique and site rotation are both part of how Mounjaro is designed to be used, so yes, they form part of the foundation for the results seen in clinical trials. In the SURMOUNT-1 trial, thousands of adults using tirzepatide alongside a reduced-calorie diet and increased activity achieved an average body-weight reduction of around 20 to 21% at the highest dose over 72 weeks, as published in the New England Journal of Medicine. Those results were achieved under controlled conditions where injection protocols were followed carefully.
Real-world treatment rarely matches a trial's precision, but the principle holds: the more consistently you inject into well-chosen, rotating sites, the more reliable your absorption is likely to be. It is not the only factor (diet, activity, sleep and how your body responds all play a role) but it is one of the few things entirely within your control week to week.
If you are considering starting Mounjaro and want to understand the full picture of how treatment works in practice, the treatment overview is the place to start. As a prescription-only medicine, Mounjaro requires clinical assessment; a prescriber decides whether it is right for you and at what dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.